Finding the Right Breast Cancer Specialist in Shanghai — A Patient's Guide
Shanghai is home to some of Asia's most accomplished breast cancer specialists, spanning surgical oncology, medical oncology, radiation oncology, integrative medicine, and clinical research. With so many outstanding experts available, the key question for international patients is: which specialist is right for my specific situation?
This guide helps you match your clinical needs to the most appropriate specialist at Shanghai's leading hospitals, all accessible through China Medical Concierge Shanghai (CMCS).
If You Need Breast Surgery (Conservation or Reconstruction)
If surgery is your primary need — whether breast-conserving surgery, mastectomy with reconstruction, or minimally invasive approaches — the following specialists each bring a distinct surgical focus:
- Prof. Wu Kejin (吴克瑾) — Red House Hospital, Fudan University: China's leading expert in pregnancy-associated breast cancer and fertility preservation for young patients. If you are pregnant, postpartum, or concerned about future fertility, Prof. Wu is the specialist to see.
- Prof. Cai Fengfeng (蔡丰丰) — Tongji Hospital: Specializes in breast-conserving surgery and oncoplastic reconstruction, with a philosophy that equally weights oncological cure and long-term quality of life.
- Prof. Han Baoshan (韩宝三) — Xinhua Hospital: Pioneer of over 10 first-in-China breast surgery techniques, guided by his “Precise · Meticulous · Beautiful” philosophy. Ideal for patients seeking surgical innovation and superior aesthetic outcomes.
- Prof. Li Hengyu (李恒宇) — Changhai Hospital: Director of Breast and Thyroid Surgery with over 1,100 procedures per year, specializing in minimally invasive breast and thyroid surgery. Ideal for patients requiring both breast and thyroid evaluation.
If You Have Triple-Negative or Hard-to-Treat Breast Cancer
Triple-negative breast cancer (TNBC) and other difficult subtypes require specialized expertise. Two of China's most advanced TNBC protocols are available in Shanghai:
- Prof. Jiang Yizhou (江一舟) — Fudan University Shanghai Cancer Center: Creator of the "Fudan Classification" (复旦分型) — a molecular subtyping system that nearly triples treatment response rates in refractory TNBC (from 10% to 29.8%). If you have been told your TNBC is not responding to standard chemotherapy, Prof. Jiang's precision approach may offer new options.
- Prof. Shen Kunwei (沈坤炜) — Ruijin Hospital: Principal investigator of the "Ruijin Protocol" (EC-TCb), which reduces recurrence risk by 34% and mortality risk by 61% in early-stage TNBC. If you have early TNBC and are planning adjuvant chemotherapy, Prof. Shen's protocol represents China's most evidence-backed approach.
If You Need Precision Radiation Therapy
- Prof. Chen Jiayi (陈佳艺) — Ruijin Hospital: Lead author of the CSCO national breast cancer radiotherapy guidelines and one of China's first scholars to conduct proton therapy research for breast cancer. If you have left-sided breast cancer, require post-mastectomy radiation, or want to minimize cardiac and pulmonary radiation exposure, Prof. Chen is China's foremost authority.
If You Have Recurrent or Metastatic Breast Cancer
- Prof. Wang Hongxia (王红霞) — Fudan University Shanghai Cancer Center: Specializes in recurrent and metastatic breast cancer and immunotherapy for solid tumors. Her team treats over 500,000 patient visits per year for advanced breast cancer — an unmatched volume of experience with complex, refractory, and late-stage presentations. National Jieqing and Young Women in Science awardee.
If You Want Integrative TCM Support Alongside Western Treatment
- Prof. Zheng Lan (郑岚) — Ruijin Hospital: Director of TCM at Ruijin Hospital, specializing in integrative Chinese and Western medicine for breast cancer. Her protocols reduce chemotherapy side effects, support immune recovery, manage endocrine therapy symptoms, and provide long-term survivorship support — all within Ruijin's multidisciplinary oncology ecosystem.
If You Want Access to Clinical Trials and the Latest Research
- Prof. Qin Wenxing (秦文星) — Fudan University Shanghai Cancer Center (Shanghai & Xiamen): CSCO guideline co-author and principal investigator on multiple domestic and international breast cancer clinical trials. If you are interested in accessing novel agents not yet commercially available, or enrolling in a trial that places you alongside patients at leading Western cancer centers, Prof. Qin is the specialist to consult.
Quick Reference: Specialist Matching Guide
| Your Situation | Recommended Specialist | Hospital |
|---|---|---|
| Pregnant / postpartum / fertility concerns | Prof. Wu Kejin | Red House Hospital |
| Breast conservation or reconstruction | Prof. Cai Fengfeng | Tongji Hospital |
| Surgical innovation & aesthetic outcomes | Prof. Han Baoshan | Xinhua Hospital |
| Minimally invasive / breast + thyroid | Prof. Li Hengyu | Changhai Hospital |
| Refractory TNBC / precision subtyping | Prof. Jiang Yizhou | FUSCC |
| Early TNBC adjuvant chemotherapy | Prof. Shen Kunwei | Ruijin Hospital |
| Radiation / proton therapy | Prof. Chen Jiayi | Ruijin Hospital |
| Recurrent / metastatic breast cancer | Prof. Wang Hongxia | FUSCC |
| TCM integrative support | Prof. Zheng Lan | Ruijin Hospital |
| Clinical trials & latest research | Prof. Qin Wenxing | FUSCC / Xiamen |
Important Note
Specialist clinic schedules and availability may change. We recommend confirming appointment availability through the hospital's official app, WeChat mini-program, or by contacting CMCS directly before traveling to Shanghai.
If you would like to learn more about any of these specialists or treatment approaches, our team is happy to provide additional information and help you determine which expert is best suited to your specific case.
Contact CMCS
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 commentaire